- 神経治療学 (ISSN:09168443)
- vol.38, no.4, pp.661-665, 2021 (Released:2022-04-28)
The effect of immune checkpoint inhibitors has become clear, and its indication is expanding. Contrary to its effects, immune related adverse events (irAE) have become a problem. Neurologic irAE are relatively rare, yet potentially fatal. Neurologists should make appropriate diagnoses and treatments.